Anthony Stephan: EMPowerplus Effective for ADHD and ‘Mood Disorders’ Feb 6 & Feb 13

Listen to this audio archive program of Anthony Stephan: EMPowerplus Effective for ADHD and ‘Mood Disorders’ Feb 6 & Feb 13

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

All I can say is WOW! One determined father, to save his children from a life on drugs and psych wards, one company, one product EMPowerplus – 24 independent published studies – changing how we view health care.  Yes, folks – it is health care not drug care – Micronutrients are the baseline for optimum health. Drugs mask the symptoms. Interview is archived here and on my host page on VoiceAmerica.

This powerful interview will be re-run on February 13. Please share with those who suffer from ADHD, depression and other disorders.

BOTHA Banner v smControversial EMPowerplus Supplement
Proven Effective for ADHD & ‘Mood Disorders’
with Anthony Stephan
Holy Hormones Honey!
February 6
VoiceAmerica Health and Wellness Channel
Noon ET; 11 am CT; 10 am MT; 9 am PT

On Thursday, January 30, Truehope Inc.’s first Random Control Trial publication titled:  Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults:  double-blind randomized placebo-controlled trial by Julia J. Rucklidge, Chris M. Frampton, Brigette Gorman and Anna Boggis made the BBC News as well as other major business journals around the country.

This historic publication of a trial on the EMPowerplus nutritional supplement for mood disorders and ADHD – without side effects will change the paradigm of how we look at mental/emotional imbalances in the body.

Would you consider a 47.6% outcome for a study on mood disorders significant? What would you say if this published study was on a micronutrient supplement and not a drug?

Last week, a ground-breaking study published in the British Medical Journal cited that researchers at the University of Canterbury in NZ found the micronutrient supplement Truehope EMPowerplus™ had significant benefits for adults with psychiatric symptoms of ADHD, depression, hyperactivity, impulsivity and inattention.  The research publication also identified a major reduction in symptoms in those suffering from ‘moderate’ to ‘severe’ depression.

Truehope founder, Anthony Stephan believes that this research now places EMPowerplus™ in a new class of first line treatments for the most common mood disorders.  The safety profile of the product has been researched extensively and has been proven to be safe in use over the past 16 years.Tony3-web 2

EMPowerplus™ has now been the subject of 24 medical journal publications.

Anthony Stephan is the founder of Truehope Inc., the leaders of brain health. His quest to find a natural solution for bipolar disorder started with a personal tragedy – the suicide of his wife, who battled bipolar her entire life, and the discovery that two of his nine children were afflicted with the disease. Through his hard work, he helped his children reclaim their lives. But he didn’t stop there – to date, he’s helped over 100,000 people through the Truehope Program, in over 600 countries.  There are now over 20 independent journal publications on his product.

For Stephan, the assurances of a Calgary psychiatrist, that his uncontrollable teenage son would never improve, and instead deteriorate was the prod to find an answer.  He was told he should prepare for another suicide in his family. “That hit me in the gut. Something snapped. I was not prepared to accept that God would put people on the Earth to suffer like this. There had to be an answer.”

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.